Esbriet (pirfenidone)

pCPA File Number: 20728
Negotiation Status:
Concluded with an LOI
Indication(s):
Pulmonary fibrosis (idiopathic, mild to moderate)
Sponsor/Manufacturer:
Hoffmann-La Roche Ltd.
CDA-AMC Project Number:
SR0292-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: